RE:Just my opinion!NXO was a crock, they abandoned their true product, Double Take, to focus on ALIIS. The net results is a very bad stock price. They made bad decisions.
THRM is moving in the right direction, and testing is still required in many places and there are many countries that require it to help curb their Covid issues.
The world, overall, is on a slight upswing.
Just have to wait out when approvals may happen.